Biotech Bombshell: Recursion Pharmaceuticals Soars to Shocking New Heights! Leonardo Martins 02/18/2025
Eli Lilly Stock Soars or Dives? Shocking Q2 Trial Results Hang in the Balance! Marcel Trisent 02/15/2025
Akeso’s Gumokimab Monoclonal Antibody (IL-17) New Drug Application for the Treatment of Moderate to Severe Psoriasis Accepted by NMPA By Investing.com Leonardo Martins 01/27/2025
Purdue Pharma and Sackler Family Shockingly Strike $7.4 Billion Deal Over Opioid Crisis! Eniato Finance 01/23/2025